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Abstract. 
 
The binding of Fas ligand to Fas recruits 
caspase 8 to Fas via an adaptor, FADD/MORT1, and 
activates a caspase cascade leading to apoptosis. Here, 
we describe a human Jurkat-derived cell line (JB-6) 
that is deficient in caspase 8. This cell line was resistant 
to the apoptosis triggered by Fas engagement. How-
ever, the multimerization of Fas-associated protein 
with death domain, through the use of a dimerizing sys-
tem, killed the JB-6 cells. This killing process was not 
accompanied by the activation of caspases or DNA 
fragmentation. The dying cells showed neither conden-
sation nor fragmentation of cells and nuclei, but the 
cells and nuclei swelled in a manner similar to that seen 
in necrosis. These results suggested that Fas-associated 
protein with death domain can kill the cells via two 
pathways, one mediated by caspases and another that 
does not involve them.
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 categories of cell death have been defined: apop-
tosis and necrosis (Kerr et al., 1972). The apoptotic
process is accompanied by condensation and frag-
mentation of cells and nuclei, as well as by degradation of
the chromosomal DNA into nucleosomal units (Wyllie
1980; Wyllie et al., 1980). The necrotic process is charac-
terized by swelling and disintegration of the cells and nu-
clei. Most apoptotic processes are mediated by a family of
cysteine proteases called caspases (Cohen, 1997; Nichol-
son and Thornberry, 1997). Caspases are activated by vari-
ous apoptotic stimuli and cleave cellular substrates such as
poly(ADP-ribose) polymerase (PARP),
 
1
 
 lamin, actin, p27,
and inhibitor of caspase-activated DNase, which is respon-
sible to cause morphological changes of nuclei, and degra-
dation of chromosomal DNA. The molecular mechanism
of the necrotic cell death process, however, is not well un-
derstood.
Fas ligand (FasL) is a member of the tumor necrosis fac-
tor (TNF) family. By binding to Fas, its receptor, FasL in-
duces apoptosis (Baker and Reddy, 1996; Nagata, 1997).
This apoptotic process proceeds by the binding of an adap-
tor molecule, Fas-associated protein with death domain
(FADD), to the death domain of the Fas cytoplasmic re-
gion. This binding causes recruitment of pro-caspase 8 to
the Fas receptor to establish the death-inducing signaling
complex (DISC) (Kischkel et al., 1995). Pro-caspase 8 is
processed at the DISC to the mature active enzyme, and
activates other caspases, such as caspase 3, in the down-
stream of the caspase cascade. In this report, we describe a
Jurkat-derived cell line that does not express caspase 8.
This cell line was resistant to Fas-induced cell death. How-
ever, multimerization of FADD in this cell line killed the
cells. This killing process proceeded without caspase acti-
vation, and was accompanied neither by apoptotic mor-
phological changes of the cells nor by DNA fragmenta-
tion. An analysis of the dying cells under the electron
microscopy indicated that this process was accompanied
by necrotic morphological changes. 
 
Materials and Methods
 
Establishment of Stable Transformants
 
Plasmid MF2FE carries a DNA fragment coding for the FK506 binding
protein (FKBP)ÐFas chimeric molecule that is consisting of the cytoplas-
mic region of Fas, two tandem repeats of FKBP12, the myristilation-tar-
geting peptide, and the influenza hemagglutinin (HA) epitope (see Fig. 2
 
Dr. KawaharaÕs present address is Laboratory of Molecular Genetics, Na-
tional Institute of Child Health and Human Development, NIH, Be-
thesda, MD 20892.
Address all correspondence to Shigekazu Nagata, Osaka University
Medical School, B-3, Department of Genetics, 2-2 Yamada-oka, Suita,
Osaka 565-0871, Japan. Tel.: 81-6-879-3310. Fax: 81-6-879-3319. E-mail:
nagata@genetic.med.osaka-u.ac.jp
 
1. 
 
Abbreviations used in this paper:
 
 FADD, Fas-associated protein with
death domain; FKBP, FK506 binding protein; HA,
 
 
 
hemagglutinin; PARP,
poly(ADP-ribose) polymerase; TNF, tumor necrosis factor.
  
The Journal of Cell Biology, Volume 143, 1998 1354
 
A
 
). The coding region of FKBP-Fas was excised from pMF2FE (Spencer et
al., 1996) (provided by Dr. M. Gilman in ARIAD, Cambridge, MA), and
inserted in pEF-BOS expression vector to generate pEF-FKBP-Fas. The
expression vector for FKBP-FADD (pEF-FKBP-FADD) was constructed
by replacing the Fas cytoplasmic region of pEF-FKBP-Fas by the entire
coding region of FADD/MORT1 (Boldin et al., 1995; Chinnaiyan et al.,
1995). To construct the expression vector for human caspase 8, the entire
coding region of human caspase 8 (Boldin et al., 1996; Muzio et al., 1996)
was fused in frame with the sequence of FLAG epitope, and inserted in
pEF-BOS vector (Mizushima and Nagata, 1990) to generate pEF-CAS8.
Jurkat is a human leukemic T lymphoma cell line, and JB-6 is a Jurkat-
derived cell line that overexpresses human Bcl-2. To establish stable trans-
formants expressing FKBP-Fas, FKBP-FADD, or human caspase 8, Jur-
kat and JB-6 cells (10
 
7
 
) were cotransfected with 50 
 
m
 
g of the expression
vectors (pEF-FKBP-Fas, pEF-FKBP-FADD, or pEF-CAS8) with 1 
 
m
 
g of
the hygromycin-resistant gene (pMiwhyg) by electroporation using a
Gene Pulser (Bio-Rad Laboratories, Hercules, CA) as described previ-
ously (Suda et al., 1993). The hygromycin-resistant clones were selected
by culturing cells in the presence of 800 
 
m
 
g/ml of hygromycin. The trans-
formant clones expressing FKBP-Fas, FKBP-FADD, or caspase 8 were
then identified by Western blotting using antiÐHA, antiÐFADD antibody,
or antiÐFLAG antibody, respectively. JF and JM clones were Jurkat-
derived cells expressing FKBP-Fas and FKBP-FADD, respectively.
Whereas, BC, BF, and BM clones were JB-6-derived cells expressing hu-
man caspase 8, FKBP-Fas, and FKBP-FADD, respectively.
 
Cell Viability Assay
 
The cell viability was determined by the WST-1 assay (Kawahara et al.,
1998
 
b
 
) or 
 
3
 
H-thymidine incorporation. In brief, 5 
 
3 
 
10
 
4
 
 cells were stimu-
lated with various concentrations of FK1012 for 6 h in 100 
 
m
 
l. The WST-1
reagent, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)
 
2
 
[H] tet-
razolium monosodium salt (Dojin Laboratories, Kumamoto, Japan), and
1-methoxy-5-methylphenazinium methylsulfate were added to the cells at
the final concentrations of 5 and 0.2 mM, respectively, and incubated for
1 h. The cell viability was determined by measuring the difference be-
tween the absorbance at 450 and 620 nm using an ELISA autoreader. For
 
3
 
H-thymidine incorporation assay, 3 
 
3 
 
10
 
4
 
 cells were incubated with 0.5
 
m
 
M of FK1012 for 20 h in 100 
 
m
 
l, and then pulsed with 1 
 
m
 
Ci of 
 
3
 
H-thymi-
dine (6.7 Ci/mmol; Dupont-NEN, Boston, MA) for 4 h before harvest.
 
Assay for Caspase Activity
 
The caspase activity in the cell lysates was determined as described (Enari
et al., 1996). In brief, the cell lysates (S-30 fraction, 10 
 
m
 
g) were incubated
for 30 min at 30
 
8
 
C in 0.5 ml of the assay buffer (100 mM HEPES-KOH,
pH 7.5, 10% sucrose, 0.1% CHAPS, 10 mM DTT, and 0.1 mg/ml ovalbu-
min) containing 1 
 
m
 
M MCA-DEVDAPK(dnp) (Peptide Institute, Osaka,
Japan). The fluorescence was measured at an excitation wavelength of 325
nm and an emission wavelength of 395 nm using a spectrofluorometer
(RF-1500; Shimadzu, Tokyo, Japan).
 
Western Blotting and DNA Fragmentation
 
Cells were incubated on ice for 30 min in the lysis buffer (20 mM Tris-
HCl, pH 7.5, 140 mM NaCl, 1% Triton X-100, 2 mM EDTA, 1 mM 
 
p
 
-ami-
dinophenyl methanesulfonyl fluoride hydrochloride, 50 mM NaF, 1 mM
Na
 
3
 
VO
 
4
 
, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, 10% glycerol). After re-
moving insoluble materials by centrifugation, the supernatant was recov-
ered as cytosolic extracts. In some cases, the crude lysates were prepared
by heating the cells at 85
 
8
 
C for 30 min in 100 
 
m
 
l of lysis buffer (2.5% SDS,
120 mM Tris-HCl, pH 6.8, 200 
 
m
 
M DTT, 20% glycerol). The lysate was
then mixed with 100 
 
m
 
l of 2
 
3 
 
LaemmliÕs sample buffer.
Western blotting was performed as previously described (Kawahara et al.,
1998
 
a
 
). AntiÐhuman caspase 8 (clone 5F7) antibody was purchased from
Medical and Biological Laboratories (Nagoya, Japan). AntiÐLamin B1
and antiÐ
 
a
 
-tubulin antibodies were from Oncogene Science (Cambridge,
MA), and antiÐhuman FADD and antiÐhuman caspase 3 antibodies were
from Transduction Laboratories (Lexington, KY). AntiÐHA and antiÐ
human Bcl-2 antibodies were from Boehringer Mannheim Biochemicals
(Indianapolis, IN) and from PharMingen (San Diego, CA), respectively.
AntiÐhuman PARP antibody (clone C-2-10) was provided by Dr. G.G.
Poirier (Centre Hospitalier de lÕUniversit Laval Research Center, Que-
bec, Canada). Proteins recognized by the primary antibody were visual-
ized using the enhanced chemiluminescence system (Renaissance; Du-
pont-NEN) after reacting with the horseradish peroxidaseÐconjugated
antiÐmouse IgG (DAKO
 
 
 
Corp., Santa Barbara, CA). DNA fragmenta-
tion assay was performed as described previously (Enari et al., 1995).
 
Results
 
Requirement of Caspase 8 for Fas-induced Apoptosis
 
During establishment of Jurkat cell transformants overex-
pressing Bcl-2, we obtained a clone (JB-6) that was com-
pletely resistant to Fas-induced cell death (Fig. 1 
 
A
 
). This
cell line, JB-6, expressed Fas as abundantly as the parental
Figure 1. Resistance of human Jurkat cell variants to the Fas-
induced apoptosis. (A) The Fas-induced apoptosis of human Jur-
kat and its variant cell lines. Human Jurkat, its variant (JB-6)
lacking caspase 8, and JB-6 transformants (BC-18 and BC-22) ex-
pressing the FLAG-tagged caspase 8 were incubated for 15 h
with the indicated concentrations of the antiÐFas antibody
(CH11; lot 170). The cell viability was determined by the WST-1
assay as described in Materials and Methods, and is expressed as
the percentage of that observed without the antiÐFas antibody
treatment. (B) Expression of caspase 8 in Jurkat-derived JB-6
cells. The crude cell lysates were prepared from Jurkat, JB-6, BC-
18, and BC-22 by lysing them with a high concentration of SDS.
The lysates (derived from 5 3 104 cells/lane) were separated by
electrophoresis on 10% or 10/20% polyacrylamide gel, followed
by Western blotting analysis using antibodies against caspase 8,
Bcl-2, Fas, FADD, and caspase 3. The corresponding bands are
indicated by arrows on the right. 
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Figure 2
 
. Killing of cells by oligomerization of Fas and FADD.
(
 
A
 
) A schematic representation of the chimeric molecules,
FKBP-Fas and FKBP-FADD. FKBP, Fas, and FADD represent
a domain of human FKBP12 from the amino acid position from 2
to 107, the cytoplasmic domain of Fas (residues 179Ð319), and the
entire coding region of FADD, respectively. Myr and HA indi-
cate the myristilation targeting peptide and influenza hemaggluti-
nin epitope, respectively. (
 
B
 
) Expression of the chimeric mole-
cules, FADD, and caspases in Jurkat-derived cell lines. JF-1 and
-19 clones are Jurkat cells transformed with FKBP-Fas, while
JM-84 and -94 are Jurkat cells transformed with FKBP-FADD.
The JB-6 cells were also transformed with FKBP-Fas (BF-2 and
BF-4) or FKBP-FADD (BM-5 and BM-79). The cytosolic ex-
tracts (derived from 2.5 
 
3 
 
10
 
5 
 
cells/lane) prepared from the indi-
cated cells were separated on SDS-PAGE and analyzed by West-
ern blotting with antibodies against HA, FADD, caspase 8, and
caspase 3. Arrows indicate the positions of respective molecules.
(
 
C
 
) Effect of FK1012 on the cell viability. Cells were incubated at
37
 
8
 
C for 6 h with the indicated concentrations of FK1012, and the
cell viability was determined by the WST-1 method. Results are
expressed as percentage of that obtained without FK1012. The
experiments were done in triplicate, and the average values are plotted. (
 
D
 
) Effect of FK1012 on the 
 
3
 
H-thymidine incorporation. The
indicated transformant clones (3 
 
3 
 
10
 
4
 
 cells/100 
 
m
 
l) were incubated at 37
 
8
 
C for 20 h in the presence of 0.5 
 
m
 
M FK1012. The cells were
then pulsed with 
 
3
 
H-thymidine, and the radioactivity incorporated into the cells were determined as described in Materials and Meth-
ods. Results are expressed as percentage of that obtained without FK1012. The experiments were done in triplicate, and the average val-
ues are shown with the standard deviation indicated by bars. 
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Jurkat cells (Fig. 1 
 
B
 
); however, it expressed very little, if
any, caspase 8 (Fig. 1 
 
B
 
). Other signaling molecules, such
as FADD and caspase 3, were expressed in JB-6 cells as
abundantly as in Jurkat cells. The expression level of
caspase 10 (Mch 4, FLICE 2), which is another caspase
containing the death effector domain (Fernandes-Alnemri
et al., 1996; Vincenz and Dixit, 1997), was also comparable
between Jurkat and JB-6 cells (data not shown). These re-
sults suggested that the resistance of this cell line to Fas-
induced apoptosis was likely due to the lack of caspase 8.
Accordingly, when an expression vector for human
caspase 8 was introduced into the JB-6 cell line, the trans-
formants (BC clones) regained the sensitivity to Fas-induced
apoptosis (Fig. 1,
 
 A
 
 and 
 
B
 
).
 
Oligomerization of FADD Kills the Cells
Lacking Caspase 8
 
It is assumed that the engagement of Fas causes oligomer-
ization of FADD, which leads to activation of caspase 8
(Boldin et al., 1996; Muzio et al., 1996). To examine
whether the oligomerization of FADD causes cell death,
two copies of FKBP (FK506-binding protein) were joined
to the death domain of human Fas (Itoh and Nagata, 1993)
or to full-length human FADD (Boldin et al., 1995; Chin-
naiyan et al., 1995; Fig. 2 
 
A
 
), and introduced into Jurkat
cells or JB-6 cells. As shown in Fig. 2 
 
B
 
, the Jurkat-derived
transformant clones JF-1 and -19, and the JB-6Ðderived
BF-2 and -4 clones all expressed FKBP-Fas of 44 kD, 
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which was recognized by the antiÐHA antibody. In addi-
tion, the Jurkat-derived JM-84 and -94 clones, as well as
the JB-6-derived BM-5 and -79 clones, expressed a FKBP-
FADD of 50 kD, detected by an antiÐhuman FADD anti-
body. The expression level of the FKBP-FADD was com-
parable with that of the endogenous FADD, which is 32 kD
(Fig. 2 
 
B
 
). As found in the parental JB-6 cells, all transfor-
mant clones derived from JB-6 were deficient in express-
ing caspase 8. However, the expression levels of the en-
dogenous Fas, FADD, and caspase 3 were comparable
among all transformants (Fig. 2 
 
B
 
,
 
 
 
and data not shown).
The transformants were then treated for 6 h with in-
creasing concentrations of FK1012, which should induce
FKBP dimerization (Spencer et al., 1993, 1996), and thus
oligomerization of FKBP-Fas or FKBP-FADD. As shown
in Fig. 2 
 
C
 
, FK1012 did not show any toxicity to the paren-
tal Jurkat or JB-6 cells at a concentration of 0.5 
 
m
 
M. When
Jurkat cell transformants expressing FKBP-Fas or FKBP-
FADD were treated with FK1012, viability (as assayed by
the WST-1 method) was lost, indicating that the oligomer-
ized FKBP-Fas or FKBP-FADD could kill the cells. The
JB-6 transformants expressing FKBP-Fas were resistant to
the FK1012-induced cell death, and 
 
.
 
65% of the cells
were still alive after treatment with 0.5 
 
m
 
M of FK1012 for
6 h. These results were consistent with the observation
that JB-6 cells were resistant to the antiÐFas antibody-
induced cell death as described above (Fig. 1 
 
A
 
). On the
other hand, the JB-6 transformants expressing FKBP-
FADD were efficiently killed by FK1012 (Fig. 2 
 
C
 
). The
sensitivity of these cells to FK1012 was comparable to that
found with Jurkat cell transformants expressing FKBP-
FADD. The cell viability was also assayed by 
 
3
 
H-thymi-
dine uptake. As shown in Fig. 2 
 
D
 
, the cells were incu-
bated for 20 h with 0.5 
 
m
 
M of FK1012, and then pulsed for
4 h with 
 
3
 
H-thymidine. The Jurkat cell transformants (JF
and JM clones) expressing FKBP-Fas or FKBP-FADD
lost the ability to incorporate thymidine. The JB-6 trans-
formants expressing FKBP-Fas (BF clones) survived after
treatment with FK1012, while the BM clones expressing
FKBP-FADD were efficiently killed by the same treat-
ment.
 
Necrotic Death Caused by FADD
 
The above results indicated that the killing of cells by oli-
gomerization of Fas requires caspase 8. However, FADD,
which mediates the Fas signal to caspase 8, can kill cells
without caspase 8. To examine the molecular mechanism
behind the FADD-induced cell death, activation of cas-
pase 3 and DNA fragmentation were analyzed in Jurkat
and JB-6 transformant clones. As shown in Fig. 3, 
 
A
 
 and
 
D
 
, when the Jurkat cell transformants were treated with
FK1012, the proforms of caspases 8 and 3 disappeared
within 6 h. This processing of caspases was accompanied
by a strong activation of caspase 3Ðlike protease, the cleav-
age of PARP and lamin B1, and the degradation of chro-
mosomal DNA (Fig. 3). On the other hand, the JB-6 cell
transformants expressing FKBP-Fas did not show any pro-
teolysis of the nuclear proteins lamin B1 and PARP, nor
any DNA fragmentation, as predicted by their unrespon-
siveness to FK1012 treatment. The transformants express-
ing FKBP-FADD also showed neither caspase 3 activation
nor DNA degradation by the treatment with FK1012, de-
spite massive cell death. These results indicated that oligo-
merization of FADD can kill the cells without activating
caspases or causing DNA fragmentation. The dying cells
were then examined using transmission electron micros-
copy. As shown in Fig. 4, death of Jurkat cells induced by
Figure 3. Biochemical characterization of the cell death induced
by FKBP-Fas or FKBP-FADD. (A) Proteolysis of caspase 8 and
nuclear proteins. The indicated cells were incubated at 378C for 6 h
without (2) or with 0.5 mM FK1012 (FK) or 0.5 mg/ml antiÐFas
antibody (CH11) (Fas). The cells were lysed with 2.5% SDS, and
the crude lysates were subjected to the Western blotting analysis
with the antibodies against caspase 8, PARP, lamin B1, and a-tubu-
lin. Arrows indicate the positions of respective molecules. (B)
DNA degradation. The indicated cells were incubated at 378C for
6 h without (2) or with 0.5 mM FK1012 (FK) or 0.5 mg/ml antiÐ
Fas antibody (CH11) (Fas). Total DNA was extracted from the
cells and electrophoresed on a 1.5% agarose gel in the presence
of 1.0 mg/ml ethidium bromide. (C) Activation of caspase 3Ðlike
protease activity. The indicated cells were stimulated for 4 h with
or without 1 mM FK1012. The caspase 3Ðlike protease activity
was then determined with 10 mg of the cell lysates (S-30 fraction)
and 1 mM fluorogenic substrate, MCA-DEVDAPK(dnp), as de-
scribed in Materials and Methods. The caspase activity is ex-
pressed as an arbitrary unit. 1 ng of the recombinant caspase 3
gave 220 arbitrary units under the same conditions. (D) Process-
ing of caspase 3. The indicated cells were incubated at 378C for
4 h with 1 mM FK1012. The cell lysates (S-30 fraction, 20 mg/lane)
were then subjected to the Western blotting analysis using antiÐ
caspase 3 antibody. The proform of 32 kD and active processed
form of 17 kD are indicated by arrows. 
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oligomerization of FKBP-Fas or FKBP-FADD was ac-
companied by apoptotic morphological changes such as
chromatin condensation, cell shrinkage, and apoptotic
bodies. On the other hand, the caspase 8Ðdeficient BM
cells dying as result of FADD oligomerization showed nei-
ther condensation of cells nor fragmentation of chromatin.
Rather, the cells swelled without forming apoptotic bod-
ies. These results indicated that FADD can kill cells with-
out inducing apoptosis in BM cells.
We then examined the effect of a broad caspase inhibi-
tor, Z-VAD-fmk, on the cell death in Jurkat cells. As
shown in Fig. 5, 
 
A
 
 and 
 
B
 
, Z-VAD-fmk completely blocked
the proteolysis of nuclear proteins and DNA fragmenta-
tion that occur during FKBP-Fas-induced cell death. Ac-
cordingly, the cell death induced by FKBP-Fas was largely
prevented by Z-VAD-fmk (Fig. 5 
 
C
 
). In contrast, Z-VAD-
fmk did not inhibit the FKBP-FADD-mediated cell death,
although it inhibited proteolysis of nuclear proteins and
DNA degradation. The dying Jurkat cells under electron
microscope showed a necrotic morphological change (Fig.
4 
 
E
 
). These results suggested that FADD can kill the Jur-
kat cells via two pathways. One is an apoptotic pathway in
which activation of a caspase cascade leads to fragmenta-
tion of chromosomal DNA, and the other is a nonapop-
totic pathway that does not involve caspases, but is accom-
panied by necrotic morphological changes of the cells.
Discussion
In this report, we have shown that a derivative of human
Jurkat cells that does not express caspase 8 was resistant to
the apoptosis induced by the activation of endogenous Fas
or oligomerization of the Fas death domain. These results
indicate that caspase 8 is indispensable for the Fas-medi-
ated apoptotic cell death process, which agrees with the re-
cent results that embryonal fibroblasts from caspase 8 null
mice are resistant to the Fas-induced apoptosis (Varfo-
lomeev et al., 1998). On the other hand, oligomerization of
FADD, an adaptor molecule that normally mediates the
Fas signal to caspase 8, could kill cells that were deficient
in caspase 8. This pathway does not use caspases to kill the
cells, and seems to operate even in the cells (the parental
Jurkat cells) that express caspase 8, because a broad
caspase inhibitor could not prevent the cell death induced
by oligomerization of FADD.
The Fas-induced cell death is so far thought to transduce
only apoptotic signal. On the other hand, TNF was shown
to transduce not only an apoptotic signal, but also a ne-
crotic signal. In particular, treatment of mouse L929 cells
with TNF produces oxidants and kills the cells by inducing
necrotic morphological changes of the cells (Vercammen
et al., 1998a). This process was shown to be enhanced
by caspase inhibitors. More recently, Vercammen et al.
(1998b) established mouse L929 cells overexpressing hu-
man Fas. When these cells were treated with the agonistic
antiÐFas antibody, they underwent apoptosis. But, caspase
inhibitors could not prevent the cell death process, and the
cells died by necrosis. This result is apparently in contrast
to our observation that the Fas engagement alone cannot
kill the caspase 8Ðdeficient human Jurkat cells. However,
the sensitivity of the cells to necrosis may depend on the
strength of the death signal evoked by Fas or FADD, the
Figure 4. Electron microgram of
Jurkat-derived cells undergoing
cell death. The Jurkat cell trans-
formant expressing FKBP-Fas
(clone JF-1, B) or FKBP-FADD
(clone JM-94, C), and JB-6 trans-
formant expressing FKBP-
FADD (clone BM-79, D) were
incubated at 378C for 4 h with 0.5
mM FK1012, and examined by
electron transmission micros-
copy using Hitachi H7100. In E,
the clone JM-94 cells were pre-
treated at 378C for 1 h in the
presence of 500 mM Z-VAD-
fmk, and then incubated at 378C
for 4 h with 0.5 mM FK1012. The
untreated Jurkat cells (A) were
also examined under electron
microscope as a control. The
untreated other cell lines
showed a similar morphology as
Jurkat cells. Bars, 1 mm.Kawahara et al. Caspase-independent Cell Killing by FADD 1359
expression level of the downstream signal transducer for
necrosis, and/or the balance between apoptotic and ne-
crotic signals. In L929 cells, a downstream molecule(s)
leading to necrosis is more abundant than in Jurkat cells,
and the necrotic signal can be easily seen with the weak
signal from the Fas receptor in the presence of caspase in-
hibitors, while its strong activation by direct oligomeriza-
tion of FADD may be necessary to activate the necrotic
pathway in Jurkat cells. FADD can also be activated by
the TNFÐTNF type I receptor system through an adaptor
molecule called TRADD (TNFR1-associated death do-
main protein; Chinnaiyan et al., 1996; Hsu et al., 1996). It
will be interesting to determine whether the TNF-induced
necrosis in L929 cells is mediated by FADD or not. In ad-
dition, the TNF-induced necrosis in L929 cells can be in-
hibited by butylated hydroxyanisole, an antiÐoxidant, sug-
gesting an involvement of oxidants in this cell death
process (Vercammen et al., 1998a). Whether or not a simi-
lar oxidant(s) is activated during necrosis by oligomeriza-
tion of FADD in Jurkat cells remains to be determined.
The FADD-mediated apoptosis occurs through recruit-
ment of pro-caspase 8 to the FADD death effector do-
main, which leads to processing of caspase 8 and the acti-
vation of the downstream caspases, such as caspase 3, and
a DNase (CAD; Nagata, 1997; Enari et al., 1998; Sakahira
et al., 1998). It would be interesting to examine whether or
not the same region of FADD is responsible for the ne-
crotic signal transduction and what kinds of molecules are
activated by FADD. The JB-6 cells abundantly express
Bcl-2, yet oligomerization of FADD killed the JB-6 cells,
suggesting that the FADD-induced necrotic cell death
cannot be inhibited by Bcl-2. This agrees with no inhibi-
tory effect of Bcl-2 on the TNF-induced cytotoxicity in
mouse L929 cells (Vanhaesebroeck et al., 1993). In any
case, the establishment of a system for studying necrosis in
the absence of caspase activation will contribute to our un-
derstanding of the molecular mechanisms underlying ne-
crosis.
We thank M. Gilman and H. Berger for the plasmid carrying FKBP and
FK1012, V.M. Dixit for human caspase 8 (FLICE) cDNA, and S. Kuma-
gai for secretarial assistance. 
This work was supported in part by a Grant-in-Aid from the Ministry
Figure 5. Effect of a caspase inhibitor on the cell death induced by FKBP-Fas or FKBP-FADD. (A) Effect of Z-VAD-fmk on Fas or
FADD-induced proteolysis of nuclear proteins. Jurkat and its transformants expressing FKBP-Fas (clone, JF-1) or FKBP-FADD
(clone, JM-94) were preincubated at 378C for 1 h in the presence or absence of 500 mM Z-VAD-fmk (Z). The cells were left untreated
(2), or treated at 378C for 6 h with 0.5 mg/ml antiÐFas antibody (Fas) or 0.5 mM FK1012 (FK). The crude lysates were prepared by lysing
the cells with 2.5% SDS, and analyzed by Western blotting with antibodies against PARP, lamin B1, and a-tubulin. The positions for in-
tact and cleaved PARP, as well as for the intact lamin B1 and a-tubulin, are indicated by arrows on the right. The each lane contains the
crude lysates derived from 2.5 3 104 cells. (B) Effect of Z-VAD-fmk on FK1012-induced DNA degradation. After preincubation with
500 mM Z-VAD-fmk, the indicated cells were incubated at 378C for 6 h in the presence of 0.5 mg/ml antiÐFas antibody (Fas) or 0.5 mM
FK1012 (FK). Total DNA was then electrophoresed on 1.5% agarose gel. (C) Effect of Z-VAD-fmk on the cell death induced by
FKBP-Fas or FKBP-FADD. The Jurkat cell transformants expressing FKBP-Fas (JF-1 and JF-19) or FKBP-FADD (JM-84 and JM-94)
were preincubated at 378C for 1 h with (hatched bars) or without (closed bars) 500 mM Z-VAD-fmk, and then treated at 378C for 6 h with
0.5 mM FK1012. The cell viability was determined by the WST-1 assay, as described in Materials and Methods, and is expressed as a per-
centage of that obtained without FK1012 treatment.The Journal of Cell Biology, Volume 143, 1998 1360
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